Correcting social, economic and health-care inequalities may have the most significant impact in reducing survival differences in colorectal cancer between African-Americans and Caucasians, according to a new study.
FDA seized all implantable medical devices from Shelhigh, Inc., after finding significant deficiencies in the company’s manufacturing processes.
Nephron sparing surgery for localized renal tumors has gained increasing acceptance as a standard of care in appropriately selected patients.
Despite campaigns to discourage people from junk food and sedentary lifestyles, more Asians are turning to surgery to counter obesity as health authorities’ efforts to get people to exercise and eat healthier are apparently failing.
Investigators at St. Jude Children?s Research Hospital say they have found the best way for predicting when patients will need future surgery to repair hip joints that have deteriorated because of pediatric leukemia or lymphoma treatment.
University of Queensland researchers are using nanotechnology to revolutionise medical diagnostic testing of diseases such as cervical cancer.
A DEVICE that sounds like a 21st century version of a medicinal leech may soon be set loose inside the chests of heart patients. Resembling a robotic caterpillar, it will crawl across the surface of their beating heart, delivering treatment without the need for major surgery.
Researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, have determined that children and young adults with a form of cancer called sarcoma are at increased risk of having a thromboembolic event (TE) in their veins. Thromboembolic events can be a blood clot in a vessel that can interfere with normal blood flow.
Following a report of the analysis of data from the SEER registries of the NCI, showing that the incidence of breast cancer fell by 6.7 percent in 2003 in the US, and the suggestion that the data might be linked to the decrease in the use of postmenopausal hormones, the IMS advises caution in linking these two trends and recommends that hormone therapy be prescribed whenever indicated.
A team of researchers led by Professor Richard Gordon and Associate Professor Michael Stowasser has found primary aldosteronism (PAL) ? a type of high blood pressure that can be cured by surgery ? to be ten times more common than was previously suspected. Once thought to be rare, the Endocrine Hypertension Research Centre found PAL in 10% of all hypertension sufferers, making it the commonest known curable cause.